Please login to the form below

Not currently logged in
Email:
Password:

CTCL

This page shows the latest CTCL news and features for those working in and with pharma, biotech and healthcare.

FDA clears Kyowa Kirin’s skin lymphoma therapy Poteligeo

FDA clears Kyowa Kirin’s skin lymphoma therapy Poteligeo

Both MF and SS are a rare form of non-Hodgkin’s lymphoma (NHL) collectively known as cutaneous T-cell lymphomas (CTCL), and are notoriously hard to treat.

Latest news

  • Seattle Genetics claims key US approval for Adcetris Seattle Genetics claims key US approval for Adcetris

    Last November it was granted FDA approval in adult patients with cutaneous T cell lymphoma (CTCL) and there is more to come.

  • Takeda bags EU approval for Adcetris in lymphoma Takeda bags EU approval for Adcetris in lymphoma

    Takeda bags EU approval for Adcetris in lymphoma. Data shows the drug improves PFS and symptom burden in CTCL patients. ... The approval of Adcetris in this setting brings a much needed, effective treatment option to patients living with CTCL, ”she

  • EU nod for Actelion's skin cancer drug Ledaga EU nod for Actelion's skin cancer drug Ledaga

    fungoides-type cutaneous T-cell lymphoma (MF-CTCL) in patients who have received prior skin-directed therapy. ... Mechlorethamine has been used for years as an intravenous treatment for MF-CTCL, and Valchlor also has to compete with unapproved topical

  • Novartis' Farydak gets nod for myeloma in Europe Novartis' Farydak gets nod for myeloma in Europe

    Other HDAC inhibitors such as Merck &Co's first-to-market Zolinza (vorinostat) - which is approved to treat cutaneous T cell lymphoma (CTCL) in 2006 - have also been tested in myeloma

  • Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase

    Its lead product Photopheresis is approved by the FDA for palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) - a form of blood cancer - in patients who have ... Outside the US, Therakos Photopheresis is also used by

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Pharma deals in August 2015 Pharma deals in August 2015

    30600. Therakos. Mallinckrodt. Approved cell therapy platform for the palliative treatment of cutaneous T‐ cell lymphoma [CTCL].

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    387. Ceptaris Therapeutics / Actelion. Acquisition. Valchlor for mycosis fungoides-type CTCL (NDA). ... CTCL = cutaneous T-cell lymphoma. VLP  = virus-like particle produced in plant expression systems .

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics